ADP
70
2
ORCL
67
2
LEN
42
-6
CF
53
2
CNX
53
9
WY
48
-2
EA
55
-2
GE
71
3
AON
65
2
CRM
59
5
VLO
62
2
SHW
55
2
APA
46
-2
AAP
42
4
SYK
64
4
COST
50
2
MSFT
64
3
MCK
64
4
CMI
52
-3
FOXA
66
3
ADP
70
2
ORCL
67
2
LEN
42
-6
CF
53
2
CNX
53
9
WY
48
-2
EA
55
-2
GE
71
3
AON
65
2
CRM
59
5
VLO
62
2
SHW
55
2
APA
46
-2
AAP
42
4
SYK
64
4
COST
50
2
MSFT
64
3
MCK
64
4
CMI
52
-3
FOXA
66
3
Financhill
Back

Check Point Software Technologies Vs. MoonLake Immunotherapeutics Industry Stock Comparison

Buy
62

CHKP
Check Point Software Technologies

Last Price:
$223.60
Seasonality Move:
3.6%
Buy
66

MLTX
MoonLake Immunotherapeutics

Last Price:
$48.95
Seasonality Move:
19.44%
Buy
62
Check Point Software Technologies (CHKP) is a Buy

Is Check Point Software Technologies a Buy, Sell or Hold?

  • The current Check Point Software Technologies [CHKP] share price is $223.63. The Score for CHKP is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • CHKP is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
66
MoonLake Immunotherapeutics (MLTX) is a Buy

Is MoonLake Immunotherapeutics a Buy, Sell or Hold?

  • The current MoonLake Immunotherapeutics [MLTX] share price is $48.89. The Score for MLTX is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
  • MLTX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

CHKP Stock Price Chart

What is Check Point Software Technologies's stock price today?

  • The Check Point Software Technologies share price today is $223.63
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CHKP is experiencing buying pressure, which is a positive indicator for future bullish movement.

MLTX Stock Price Chart

What is MoonLake Immunotherapeutics's stock price today?

  • The MoonLake Immunotherapeutics share price today is $48.89
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MLTX is experiencing slight buying pressure.

CHKP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.68 Sell
Relative Strength Index (14 RSI): 53.21 Buy
Chaikin Money Flow: 156481 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (218.62 - 228.56) Buy
Bollinger Bands (100): (214.82 - 227.16) Buy

MLTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.59 Buy
Relative Strength Index (14 RSI): 66.2 Buy
Chaikin Money Flow: 106562 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (42.48 - 48.38) Buy
Bollinger Bands (100): (37.37 - 44.69) Buy

CHKP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 219.89 Buy
20-day SMA: 222.3 Buy
50-day SMA: 220.8 Buy
200-day SMA: 205.63 Buy
8-day EMA: 220.77 Buy
20-day EMA: 221.45 Buy
50-day EMA: 221.06 Buy
200-day EMA: 206.15 Buy

MLTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 47.31 Buy
20-day SMA: 45.85 Buy
50-day SMA: 42.39 Buy
200-day SMA: 45.6 Buy
8-day EMA: 47.18 Buy
20-day EMA: 45.65 Buy
50-day EMA: 43.43 Buy
200-day EMA: 43.97 Buy

Check Point Software Technologies Earnings Growth & CHKP Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.19 per share, an increase next quarter of $0.14 per share, an increase this year of $0.80 per share, and an increase next year of $0.91 per share.

MoonLake Immunotherapeutics Earnings Growth & MLTX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.33 per share, a decrease next quarter of $0.11 per share, a decrease this year of $1.20 per share, and a decrease next year of $0.62 per share.

Check Point Software Technologies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

MoonLake Immunotherapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):